| Literature DB >> 34834018 |
Peiwen Zhang1,2, Xinrong Li1,2, Shunhua Zhang1,2, Shuang Wu1,2, Qian Xiao1,2, Yang Gu1,2, Xinyu Guo1,2, Xutao Lin1,2, Lei Chen1,2, Ye Zhao1,2, Lili Niu1,2, Guoqing Tang1,2, Yanzhi Jiang1,2, Linyuan Shen1,2, Li Zhu1,2.
Abstract
Excessive fat accumulation can lead to obesity, diabetes, hyperlipidemia, atherosclerosis, and other diseases. MicroRNAs are a class of microRNAs that regulate gene expression and are highly conserved in function among species. microRNAs have been shown to act as regulatory factors to inhibit fat accumulation in the body. We found that miR-370-3p was expressed at lower levels in the fat mass of mice on a high-fat diet than in mice on a normal control diet. Furthermore, our data showed that the overexpression of miR-370-3p significantly suppressed the mRNA expression levels of adipogenic markers. Thus, miR-370-3p overexpression reduced lipid accumulation. Conversely, the inhibition of miR-370-3p suppressed 3T3-L1 preadipocyte proliferation and promoted preadipocyte differentiation. In addition, Mknk1, a target gene of miR-370-3p, plays an opposing role in preadipocyte proliferation and differentiation. Moreover, consistent results from in vitro as well as in vivo experiments suggest that the inhibition of fat accumulation by miR-370-3p may result from the inhibition of saturated fatty acids that promote the accumulation of polyunsaturated fatty acids. In conclusion, these results suggest that miR-370-3p plays an important role in adipogenesis and fatty acid metabolism through the regulation of Mknk1.Entities:
Keywords: adipogenesis; differentiation; fatty acid composition; miR-370-3p; proliferation
Mesh:
Substances:
Year: 2021 PMID: 34834018 PMCID: PMC8619113 DOI: 10.3390/molecules26226926
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1miR-370-3p is associated with adipogenesis. (A) The weight of iWAT, eWAT, BAT fat mass from HFD and NCW fed mice. (B) Triglycerides (TG) and total cholesterol (TC) were measured. (C) The mRNAs expression level of PPARγ, C/EBPa, FABP4 was measured in adipose tissues. (D) H&E staining for epididymal white adipose tissue (eWAT) from mice fed with HFD and NCW. (E) The expression of miR-370-3p and Mknk1 in eWAT from HFD- and NCW-fed mice. (F) The mRNAs expression level of miR-370-3p was quantified during the differentiation process. Scale bars were 50 μm. All results are presented as means ± SEM. n = 3 per treatment. Each treatment represents the mean of three replicates. * p < 0.05; ** p < 0.01, n.s. no significant difference.
Figure 2miR-370-3p inhibits preadipocyte proliferation. After 3T3-L1 cells were transfected with miR-370-3p mimics, inhibitors or Mimics NC and Inhibitor NC: (A) the transfection efficiency was measured using qRT-PCR; (B,C) EdU evaluated cells proliferation; (D) CCK-8 analysis; (E) the expression of genes associated with cell proliferation was measured by using qRT-PCR. Scale bars 50 μm. All results are presented as means ± SEM. n = 3 per treatment. Each treatment represents the mean of three replicates. * p < 0.05; ** p < 0.01, n.s. no significant difference.
Figure 3miR-370-3p inhibits preadipocyte differentiation. The transfection efficiency of transfection with miR-143-3p mimics or inhibitors in 3T3-L1 cells cultured in differentiation medium. (A)The transfection efficiency in 3T3-L1 cells of miR-370-3p. (B) Oil Red O staining, (C) triglycerides content, and (D) the expression of marker genes related to adipogenic, fatty acid oxidation, and fatty acid transportation synthesis. Scale bars 50 μm. All results are presented as means ± SEM. n = 3 per treatment. Each treatment represents the mean of three replicates. * p < 0.05; ** p < 0.01, n.s. no significant difference.
miR-370-3p regulates fatty acid composition in vivo.
| Fatty Acid | NC | Mimics | Significance |
|---|---|---|---|
|
| 0.29 | 0.28 | Increase NS |
|
| 0.1 | 0.11 | Increase NS |
|
| 0.16 | 0.16 | Increase NS |
|
| 0 | 0 | —— |
|
| 0.26 | 0.28 | Increase NS |
|
| 0.26 | 0.25 | Increase NS |
|
| 1.6 | 1.35 | Decrease * |
|
| 0 | 0 | —— |
|
| 0.38 | 0.4 | Increase NS |
|
| 0.87 | 0.95 | Increase * |
|
| 4.01 | 3.64 | Decrease NS |
|
| 0.24 | 0.22 | Decrease NS |
|
| 0.44 | 0.45 | Increase NS |
|
| 0 | 0 | —— |
|
| 6.59 | 4.77 | Decrease ** |
|
| 0 | 0 | —— |
|
| 7.72 | 8.63 | Increase NS |
|
| 0 | 0 | —— |
|
| 1.39 | 1.63 | Increase * |
|
| 0 | 0 | —— |
|
| 0.58 | 0.67 | Increase * |
|
| 0.62 | 0.48 | Decrease NS |
|
| 0 | 0 | —— |
|
| 0.59 | 0.61 | Increase NS |
|
| 0 | 0 | —— |
|
| 1.22 | 1.54 | Increase NS |
|
| 2.18 | 2.45 | Increase * |
|
| 0.57 | 0.63 | Increase ** |
|
| 0.49 | 0.89 | Increase ** |
|
| 0 | 0 | —— |
|
| 0 | 0 | —— |
|
| 0 | 0 | —— |
|
| 0.12 | 0.13 | |
|
| 0 | 0 | —— |
|
| 0 | 0 | —— |
|
| 1.42 | 1.97 | Increase * |
* p < 0.05; ** p < 0.01, NS means no significant difference.
Figure 4miR-370-3p regulates fatty acid composition both in vitro and in vivo. (A) Saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) content in mimic group and control group. (B) Measuring the expression of miR-370-3p in HFD-OE (high-fat-diet-induced obesity mice which overexpressed miR-370-3p), HFD- and NCW-fed mice. (C) SFA, MUFA, PUFA content in HFD and HFD-OE. (D) Triglyceride content. (E) H&E staining for adipose tissues from HFD and HFD-OE. (F) The mRNA levels of C/EBPa, PPARγ, FABP4, adipoq, ACOX2, ACSS1, CD36, ACADL, VLDL, SCD, FAS, and DGAT were measured by qRT-PCR. Scale bars 50 μm. All results are presented as means ± SEM. n = 3 per treatment. Each treatment represents the mean of three replicates. * p < 0.05; ** p < 0.01, n.s. no significant difference.
miR-370-3p regulates fatty acid composition in vitro.
| Fatty Acid | HFD-NC | HFD-OE | Significance |
|---|---|---|---|
|
| 29.4 | 36.17 | Increase NS |
|
| 10.23 | 13.32 | Increase NS |
|
| 50.51 | 61.86 | Increase NS |
|
| 1 | 1.11 | Increase NS |
|
| 263.84 | 334.95 | Increase NS |
|
| 6.2 | 6.17 | Increase NS |
|
| 5937.03 | 5544.6 | Decrease ** |
|
| 258.6 | 305.88 | Increase ** |
|
| 329.27 | 355.14 | Increase NS |
|
| 2.87 | 4.44 | Increase ** |
|
| 48,897.32 | 47,001.13 | Decrease NS |
|
| 19,479.61 | 21,348.67 | Increase NS |
|
| 586.42 | 588.27 | Increase NS |
|
| 767.72 | 832.1 | Increase NS |
|
| 21,122.84 | 21,110.67 | Decrease ** |
|
| 0 | 0 | —— |
|
| 92,141.78 | 92,929.21 | Increase ** |
|
| 0 | 0 | —— |
|
| 43,726.38 | 44,619.86 | Increase ** |
|
| 0 | 0 | —— |
|
| 3682.38 | 4043 | Increase NS |
|
| 469.59 | 446.31 | Decrease NS |
|
| 3283.17 | 3103.03 | Decrease NS |
|
| 1369.2 | 1390.44 | Increase NS |
|
| 0 | 0 | —— |
|
| 507.39 | 539.02 | Increase NS |
|
| 801.83 | 778.48 | Decrease NS |
|
| 1899.48 | 2096.02 | Increase ** |
|
| 173.99 | 184.22 | Increase ** |
|
| 72.72 | 69.17 | Decrease ** |
|
| 149.16 | 137.78 | Decrease NS |
|
| 11.57 | 12.34 | Increase NS |
|
| 12.71 | 13.08 | Increase NS |
|
| 52.09 | 51.81 | Decrease NS |
|
| 88.6 | 85.59 | Decrease NS |
|
| 1157.08 | 1157.85 | Increase NS |
** p < 0.01, NS means no significant difference.
Figure 5Mknk1 is a target gene of miR-370-3p. (A) Binding site and seed region of miR-370-3p are indicated in red. (B) Luciferase assays revealed the suppressive effect of miR-370-3p on the activity of Mknk1. (C) The protein expression level of Mknk1 48 h after transfection. (D) The expression levels of Mknk1 after cells were transfected with mimics, inhibitors, or NC. (E,F) EdU analysis, respectively. Moreover, (G) cell proliferation was evaluated at 0 h, 12 h, 24 h, and 48 h of proliferation by performing CCK-8. (H) qRT–PCR analysis of genes related to the cell cycle. (I) Cells were stained with oil red O. (J) Triglyceride content. (K) The expression levels of gene-related adipogenesis, fatty acid oxidation, and fatty acid transportation synthesis were measured by qRT-PCR. (L) Cells were stained with oil red O. (M) Triglyceride content. Scale bars 50 μm. All results are presented as means ± SEM. n = 3 per treatment. Each treatment represents the mean of three replicates. * p < 0.05; ** p < 0.01, n.s. no significant difference.